 MINNEAPOLIS, March 15, 2021 GLOBE NEWSWIRE -- Predictive Oncology NASDAQ: POAI Predictive Oncology Nasdaq: POAI, a knowledge-driven company focused on applying artificial intelligence AI to personalized medicine and drug discovery, today reported financial results for the year ended December 31, 2020 and provided an update on business activities. 